iLoF is enabling a new era of personalized medicine, by using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles, and provide screening and stratification tools in an affordable, fast, portable way.
Selected as the winner of numerous industry awards, iLoF has been featured as one of the most disruptive companies in Europe using Photonics and Artificial Intelligence to solve the biggest healthcare challenges of our time.
Joana Paiva, co-founder and CTO, with Paula Sampaio, co-founder and CSO, recognizes an opportunity to apply photonics and A.I. to detect diseases during her PhD
Joana Paiva along with co-founders, Paula Sampaio, Luis Valente and Mehak Mumtaz, begin their ‘Wild Card Journey’, to bring the technology to market
iLoF is founded and receives its first round of funding from EIT Health
iLoF establishes R&D operations at the Medical Faculty, University of Porto, and its commercial operations at the Oxford Foundry, Oxford University’s startup incubator
iLoF wins the Altice Innovation Award for startups
iLoF named one of the #50GameChangers around Oxford and the Thames Valley UK
iLoF research published in Scientific Reports (Nature Publishing)
iLoF co-founders named in Forbes’ 30 Under 30 List for Science and Healthcare
iLoF is chosen as one of the 10 DeepTech businesses at the Mayor of London’s Techinvest
iLof enters Google for Startups UK accelerator program